Riebman Jerome 4
4 · AZIYO BIOLOGICS, INC. · Filed Sep 12, 2022
Insider Transaction Report
Form 4
Riebman Jerome
Chief Medical Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-09-08+14,758→ 20,093 total - Tax Payment
Class A Common Stock
2022-09-08$7.30/sh−5,104$37,259→ 14,989 total - Exercise/Conversion
Restricted Stock Units
2022-09-08−14,758→ 0 total→ Class A Common Stock (14,758 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
- [F2]Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
- [F3]Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
- [F4]The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.